Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-25-075976

President & CEO sold 23,208 shares at $0.67 ($15,549)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-19 Sale : show line 1 in the form −23,208 $0.67 $15,549 1,063,693 D
Open-market sales · 23,208 sh · avg $0.67 · $15,549
Loading xslF345X05/ownership.xml…